190 related articles for article (PubMed ID: 19188169)
1. Differential diagnosis of pulmonary carcinoma following head and neck cancer by genetic analysis.
Geurts TW; van Velthuysen ML; Broekman F; van Huysduynen TH; van den Brekel MW; van Zandwijk N; van Tinteren H; Nederlof P; Balm AJ; Brakenhoff RH
Clin Cancer Res; 2009 Feb; 15(3):980-5. PubMed ID: 19188169
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?
Geurts TW; Nederlof PM; van den Brekel MW; van't Veer LJ; de Jong D; Hart AA; van Zandwijk N; Klomp H; Balm AJ; van Velthuysen ML
Clin Cancer Res; 2005 Sep; 11(18):6608-14. PubMed ID: 16166439
[TBL] [Abstract][Full Text] [Related]
3. Second primary tumors (SPT) of head and neck: distinguishing of "true" SPT from micrometastasis by LOH analysis of selected chromosome regions.
Giefing M; Rydzanicz M; Szukala K; Wozniak A; Wierzbicka M; Szyfter K; Kujawski M
Neoplasma; 2005; 52(5):374-80. PubMed ID: 16151577
[TBL] [Abstract][Full Text] [Related]
4. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
7. High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis.
Shimizu S; Yatabe Y; Koshikawa T; Haruki N; Hatooka S; Shinoda M; Suyama M; Ogawa M; Hamajima N; Ueda R; Takahashi T; Mitsudomi T
Clin Cancer Res; 2000 Oct; 6(10):3994-9. PubMed ID: 11051248
[TBL] [Abstract][Full Text] [Related]
8. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
[TBL] [Abstract][Full Text] [Related]
9. Evidence for common clonal origin of multifocal lung cancers.
Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
[TBL] [Abstract][Full Text] [Related]
10. A rational approach to pulmonary screening in newly diagnosed head and neck cancer.
Loh KS; Brown DH; Baker JT; Gilbert RW; Gullane PJ; Irish JC
Head Neck; 2005 Nov; 27(11):990-4. PubMed ID: 16136584
[TBL] [Abstract][Full Text] [Related]
11. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
[TBL] [Abstract][Full Text] [Related]
12. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene.
Tabor MP; van Houten VM; Kummer JA; Vosjan MJ; Vlasblom R; Snow GB; Leemans CR; Braakhuis BJ; Brakenhoff RH
Genes Chromosomes Cancer; 2002 Feb; 33(2):168-77. PubMed ID: 11793443
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
[TBL] [Abstract][Full Text] [Related]
14. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
Leng K; Schlien S; Bosch FX
J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary?
Deganello A; Franchi A; Sardi I; Pignataro L; Leemans CR; Gallo O
Cancer; 2010 Mar; 116(5):1291-7. PubMed ID: 20087960
[TBL] [Abstract][Full Text] [Related]
16. Comparative mutational profiling in the assessment of lung lesions: should it be the standard of care?
Moffatt-Bruce SD; Ross P; Leon ME; He G; Finkelstein SD; Vaida AM; Iwenofu OH; Frankel WL; Hitchcock CL
Ann Thorac Surg; 2010 Aug; 90(2):388-96. PubMed ID: 20667316
[TBL] [Abstract][Full Text] [Related]
17. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
[TBL] [Abstract][Full Text] [Related]
19. Alterations of 9p in squamous cell carcinoma and adenocarcinoma of the lung: association with smoking, TP53, and survival.
Marsit CJ; Wiencke JK; Nelson HH; Kim DH; Hinds PW; Aldape K; Kelsey KT
Cancer Genet Cytogenet; 2005 Oct; 162(2):115-21. PubMed ID: 16213358
[TBL] [Abstract][Full Text] [Related]
20. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
